AI assistant
Sending…
Qualigen Therapeutics, Inc. — Director's Dealing 2017
May 18, 2017
35251_dirs_2017-05-18_bda6040e-9f0b-4c6e-8f84-6afbdd885640.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-05-18
Reporting Person: FOEHR MATTHEW W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-18 | Common Stock | P | 18000 | $.6197 | Acquired | 35000 | Direct |
More from Qualigen Therapeutics, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Annual Report
2026
Mar 30
Regulatory Filings
2026
Feb 27
Board/Management Information
2026
Feb 17
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 29
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 6
Audit Report / Information
2025
Dec 16
Proxy Solicitation & Information Statement
2025
Dec 15